PAHC
Phibro Animal Health Corporation
34.50$
+1.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.4% | +1.7% | +7.3% | +1.0% | -3.3% | +4.1% | +13.1% | +3.8% | +4.1% | +27.4% | +17.1% | |
| – | +0.1% | +0.7% | +7.2% | +1.9% | -3.5% | +3.4% | +16.9% | +3.5% | +3.7% | +27.2% | +12.2% | |
| – | +1.1% | +3.9% | +7.5% | -0.9% | -2.9% | +5.6% | +5.2% | +4.5% | +5.0% | +27.7% | +27.9% | |
| – | +16.0% | -14.4% | +5.9% | +20.9% | +13.7% | +29.3% | +17.3% | +17.1% | +19.7% | -18.7% | – | |
| – | +3.1% | -1.9% | +11.7% | +8.0% | +3.5% | +4.7% | +5.0% | +9.7% | +14.7% | +11.4% | +8.0% | |
| – | +3.1% | -2.0% | +11.8% | +8.0% | +3.5% | +4.7% | +5.0% | +9.7% | +14.7% | +11.4% | +8.0% | |
| – | -2.2% | +14.2% | +1.0% | -25.9% | -5.6% | +8.2% | +5.5% | -9.0% | -25.8% | +107.2% | +79.6% | |
| – | +15.8% | -11.6% | -20.1% | +14.9% | +4.6% | -27.3% | +16.3% | +48.3% | +22.4% | +51.3% | +43.2% | |
| – | -2.5% | +4.8% | +9.4% | -18.8% | -22.4% | +19.7% | +8.8% | -25.2% | -79.8% | +522.9% | +102.0% | |
| – | -132.5% | – | +45.9% | -27.6% | +30.7% | -45.0% | +91.6% | -7.3% | -60.4% | +132.1% | +90.7% | |
| – | +37.2% | -21.9% | +0.5% | -15.7% | -38.7% | +62.1% | -9.6% | -33.7% | -92.6% | +1,897.7% | +106.6% | |
| – | +1.9% | +5.8% | +1.6% | -10.4% | -9.9% | +8.5% | +6.3% | -9.5% | -34.9% | +112.6% | +61.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.